Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
43.52
+0.31 (0.72%)
At close: Mar 27, 2024, 4:00 PM
43.56
+0.04 (0.09%)
After-hours: Mar 27, 2024, 7:17 PM EDT

Amphastar Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
137.5591.3962.121.448.94-5.743.659.82-2.79-10.7
Upgrade
Depreciation & Amortization
28.9527.3225.4624.1420.0814.5312.9512.1611.3112.53
Upgrade
Share-Based Compensation
20.2417.8618.6920.517.316.6817.0915.1212.829.28
Upgrade
Other Operating Activities
-3.23-47.39-8.2711.22-44.5612.725.521.46-10.669.94
Upgrade
Operating Cash Flow
183.589.1897.9957.2741.7638.1939.2138.5610.6821.05
Upgrade
Operating Cash Flow Growth
105.76%-8.99%71.12%37.12%9.35%-2.60%1.68%261.01%-49.26%-32.18%
Upgrade
Capital Expenditures
-38.17-23.61-27.46-33.86-41.56-46.56-35.1-21.38-16-20.5
Upgrade
Acquisitions
-506.41000000-12.460-18.35
Upgrade
Change in Investments
-105.93-7.791.4-1.15-8.82-0.22-2.9-0.630.21-0.17
Upgrade
Other Investing Activities
1.39-1.37-2.61-1.41-0.164.61.1-5.03-1.14-0.75
Upgrade
Investing Cash Flow
-649.12-32.78-28.67-36.42-50.53-42.18-36.89-39.5-16.93-39.77
Upgrade
Share Issuance / Repurchase
-58.14-39.91-28.87-24.43-22.29-25.05-30.75-9.914.4437.86
Upgrade
Debt Issued / Paid
501.26-2.1930.36-0.88-3.213.079.27-4.45-2.21-2.71
Upgrade
Other Financing Activities
10.9715.66-38.5123.0621.7246.9813.7621.5--3.03
Upgrade
Financing Cash Flow
454.09-26.44-37.02-2.25-3.7825.01-7.727.142.2432.12
Upgrade
Exchange Rate Effect
-0.28-0.22-0.220.35-0.1-0.270.50.082.250.85
Upgrade
Net Cash Flow
-11.829.7532.0818.96-12.6520.74-4.96.28-1.7514.24
Upgrade
Free Cash Flow
145.3465.5770.5423.410.21-8.374.1117.18-5.320.55
Upgrade
Free Cash Flow Growth
121.66%-7.05%201.30%11209.66%---76.07%---95.66%
Upgrade
Free Cash Flow Margin
22.55%13.14%16.11%6.69%0.06%-2.84%1.71%6.73%-2.11%0.26%
Upgrade
Free Cash Flow Per Share
3.011.351.480.500.00-0.180.090.38-0.120.01
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).